| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, January 2008, p. 345-347, Vol. 52, No. 1
0066-4804/08/$08.00+0 doi:10.1128/AAC.00711-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Drug Resistance and Diagnostics, Australian Army Malaria Institute, Enoggera, Queensland, Australia,1 Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, People's Republic of China,2 Hainan Provincial Center for Disease Control and Prevention, Haikou, Hainan, People's Republic of China,3 Malaria Drug Resistance and Diagnostics, Queensland Institute of Medical Research, Brisbane, Queensland, Australia4
Received 31 May 2007/ Returned for modification 27 August 2007/ Accepted 16 October 2007
Chloroquine-resistant Plasmodium falciparum was highly prevalent in Hainan, China, in the 1970s. Twenty-five years after cessation of chloroquine therapy, the prevalence of P. falciparum wild-type Pfcrt alleles has risen to 36% (95% confidence interval, 22.1 to 52.4%). The diverse origins of wild-type alleles indicate that there was no genetic bottleneck caused by high chloroquine resistance.
Published ahead of print on 22 October 2007.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |